Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

CyberKnife stereotactic radiosurgery, stereotactic radiation therapy and stereotactic body radiation therapy: Technical and clinical updates.

CyberKnife stereotactic radiosurgery, stereotactic radiation therapy and stereotactic body radiation therapy: Technical and clinical updates. Journal of radiosurgery and SBRT Kattaa, A. H., Park, D. J., Pollom, E., Rahimy, E., Chang, S. D., Wang, L., Byun, J., Soltys, S. G. 2026; 10 (1-2): 43-50

Abstract

Since its clinical implementation in 1994, the CyberKnife radiosurgical system has transformed the field of stereotactic radiosurgery. Its frameless technology pioneered the role for hypofractionation, delivering radiation in a few high-dose sessions, as well as the application of stereotactic principles for extracranial treatments. Over the years, it has experienced considerable technological evolution, each enhancing imaging precision, treatment efficiency, and system usability. Hypofractionated stereotactic body radiotherapy treatments opened new treatment paradigms across a range of pathologies, including prostate cancer, lung cancer, pancreas cancer, liver malignancies, and cardiac arrhythmia. We describe the early development of the CyberKnife, highlight technologic updates to the system over time, review selected clinical treatment outcomes, and consider novel applications in the field of radiosurgery.

View details for PubMedID 42004849

View details for PubMedCentralID PMC13007236